Variant report
Variant | esv3463167 |
---|---|
Chromosome Location | chr3:195564729-195564993 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:183)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:195564878-195564928 | PrEC | prostate: | n/a |
2 | chr3:195564878-195564928 | MCF-7 | breast: | n/a |
3 | chr3:195564878-195564928 | PFSK-1 | brain: | n/a |
4 | chr3:195564748-195564798 | HCPEpiC | choroid plexus: | n/a |
5 | chr3:195564748-195564798 | SAEC | small airway: | n/a |
6 | chr3:195564951-195565001 | AG09319 | gingival: | n/a |
7 | chr3:195564951-195565001 | BE2_C | brain: | n/a |
8 | chr3:195564748-195564798 | SKMC | muscle: | n/a |
9 | chr3:195564951-195565001 | ovcar-3 | ovarian: | n/a |
10 | chr3:195564878-195564928 | HCM | heart: | n/a |
11 | chr3:195564748-195564798 | HCF | heart: | n/a |
12 | chr3:195564878-195564928 | BJ | skin: | n/a |
13 | chr3:195564748-195564798 | AoSMC | blood vessel: | n/a |
14 | chr3:195564748-195564798 | U87 | brain: | n/a |
15 | chr3:195564878-195564928 | HL-60 | blood: | n/a |
16 | chr3:195564748-195564798 | NT2-D1 | testis: | n/a |
17 | chr3:195564748-195564798 | HNPCEpiC | eye: | n/a |
18 | chr3:195564951-195565001 | MCF-7 | breast: | n/a |
19 | chr3:195564748-195564798 | HL-60 | blood: | n/a |
20 | chr3:195564878-195564928 | LNCaP | prostate: | n/a |
21 | chr3:195564878-195564928 | AG09309 | skin: | n/a |
22 | chr3:195564878-195564928 | GM12878 | blood: | n/a |
23 | chr3:195564878-195564928 | AG09319 | gingival: | n/a |
24 | chr3:195564951-195565001 | LNCaP | prostate: | n/a |
25 | chr3:195564748-195564798 | GM19239 | blood: | n/a |
26 | chr3:195564748-195564798 | GM12892 | blood: | n/a |
27 | chr3:195564748-195564798 | SK-N-MC | brain: | n/a |
28 | chr3:195564951-195565001 | HCF | heart: | n/a |
29 | chr3:195564878-195564928 | PANC-1 | pancreas: | n/a |
30 | chr3:195564878-195564928 | T-47D | breast: | n/a |
31 | chr3:195564951-195565001 | HCM | heart: | n/a |
32 | chr3:195564878-195564928 | Hepatocyte | liver: | n/a |
33 | chr3:195564748-195564798 | AG04450 | lung: | fetal |
34 | chr3:195564748-195564798 | NB4 | blood: | n/a |
35 | chr3:195564878-195564928 | HPAEpiC | pulmonary alveolar: | n/a |
36 | chr3:195564878-195564928 | SK-N-MC | brain: | n/a |
37 | chr3:195564878-195564928 | NT2-D1 | testis: | n/a |
38 | chr3:195564748-195564798 | AG10803 | skin: | n/a |
39 | chr3:195564748-195564798 | GM12878 | blood: | n/a |
40 | chr3:195564951-195565001 | HepG2 | liver: | n/a |
41 | chr3:195564951-195565001 | AG04450 | lung: | fetal |
42 | chr3:195564748-195564798 | HepG2 | liver: | n/a |
43 | chr3:195564878-195564928 | SK-N-SH_RA | brain: | n/a |
44 | chr3:195564878-195564928 | AG10803 | skin: | n/a |
45 | chr3:195564748-195564798 | PrEC | prostate: | n/a |
46 | chr3:195564951-195565001 | MCF10A-Er-Src | breast: | n/a |
47 | chr3:195564748-195564798 | BE2_C | brain: | n/a |
48 | chr3:195564748-195564798 | RPTEC | kidney: | n/a |
49 | chr3:195564748-195564798 | SK-N-SH | brain: | n/a |
50 | chr3:195564748-195564798 | HRE | kidney: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223783 | CpG island |
ENSG00000223783 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557201193 | chr3:195564741-195564742 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs373788521 | chr3:195564754-195564755 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs542601311 | chr3:195564760-195564761 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs560912054 | chr3:195564766-195564767 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs145583022 | chr3:195564767-195564768 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs540291025 | chr3:195564773-195564774 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs564990059 | chr3:195564776-195564777 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs532711188 | chr3:195564781-195564782 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs73085396 | chr3:195564788-195564789 | Enhancers Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs6807154 | chr3:195564802-195564803 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs60834536 | chr3:195564816-195564817 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs9810584 | chr3:195564827-195564828 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs572873280 | chr3:195564834-195564835 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs6583220 | chr3:195564838-195564839 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs6583221 | chr3:195564843-195564844 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs533939751 | chr3:195564850-195564851 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs552226906 | chr3:195564851-195564852 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs60290708 | chr3:195564878-195564879 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs9810735 | chr3:195564889-195564890 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs376835031 | chr3:195564896-195564897 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs62283277 | chr3:195564897-195564898 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs113730941 | chr3:195564900-195564901 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs62283278 | chr3:195564902-195564903 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs62283279 | chr3:195564905-195564906 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs9810747 | chr3:195564912-195564913 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs138282332 | chr3:195564940-195564941 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs6583222 | chr3:195564946-195564947 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs554914027 | chr3:195564951-195564952 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113913948 | chr3:195564959-195564960 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs113725202 | chr3:195564964-195564965 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs570949060 | chr3:195564967-195564968 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs564950511 | chr3:195564989-195564990 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs147327343 | chr3:195564991-195564992 | Weak transcription | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:195556800-195566600 | Weak transcription | Spleen | Spleen |
2 | chr3:195559200-195566600 | Weak transcription | Right Atrium | heart |
3 | chr3:195564000-195566000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
4 | chr3:195564200-195564800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr3:195564600-195564800 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr3:195564600-195564800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr3:195564600-195565600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr3:195564800-195565800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr3:195564800-195566000 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr3:195564800-195566200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |